Robert Harris Schwartz - 08 Mar 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Reporting relationship: President and CEO, Director
Issuer ticker: ATEX
Reported as of: 08 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Mar 2024, 20:48:18 UTC
Prior SEC filing: 25 Aug 2023
Next SEC filing: 03 Jul 2024
Source filing: View source filing
Reporting owner signature: s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Robert Harris Schwartz filed Form 4 for Anterix Inc. (ATEX) on 12 Mar 2024.

Key facts

This page summarizes Robert Harris Schwartz's Form 4 filing for Anterix Inc. (ATEX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Mar 2024, 20:48.

Change

Previous filing in this sequence was filed on 25 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEX transaction

Common Stock

Award

Transaction value: $0
Shares: +21,528
Change %: +23%
Price: $0.000000
Shares after: 114,467
Date: 08 Mar 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATEX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +127,189
Change %
Price: $0.000000
Shares after: 127,189
Date: 08 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 127,189
Exercise price: $36.00
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the issuance of restricted stock units (the "RSUs"). 1/3 of the RSUs vest on May 22, 2025, with the remaining RSUs vesting in 2 equal annual installments thereafter.

Footnote F2

1/3 of the option shares vest and become exercisable on May 22, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.